What is ProtoKinetix, Incorporated (PKTX) stock price today?

ProtoKinetix, Incorporated (PKTX) is currently trading at $0.00.

What is PKTX P/E ratio?

ProtoKinetix, Incorporated's P/E ratio is -1.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PKTX return on equity (ROE)?

ProtoKinetix, Incorporated's return on equity (ROE) is -117.19%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ProtoKinetix, Incorporated's market cap?

ProtoKinetix, Incorporated has a market capitalization of $156632.

OTC · Biotechnology

ProtoKinetix, Incorporated (PKTX) Stock

$0.00 OTC: PKTX Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$156632
P/E Ratio	-1.00
P/B Ratio	0.40
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-117.19%
ROA	-49.14%
ROCE	-104.22%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.01

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-8.0M	$-2.0M	$-2.0M	$0	$0
Net Profit	$-8.0M	$-2.0M	$-2.0M	$0	$0
EPS	$-0.03	$-0.01	$-0.01	$0.00	$0.00
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$0	$0	$0	$0	$0
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.04
EV / EBITDA	-0.66
FCF Yield	-70.28%
Quick Ratio	0.01
Interest Coverage	0.00
Return 1Y	-94.67%
Return 3Y	-98.43%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AGNPFGrey Matters Health Inc.	$0.25	-17.12%	-0.43	$869804	0.00%
ARUXFAcrux Limited	$0.02	+0.00%	-1.90	$6.78M	0.00%
AXIMAXIM Biotechnologies, Inc.	$0.00	—	-2.00	$1.02M	0.00%
HAVLFHAVN Life Sciences Inc.	$0.00	—	-0.01	$2565	0.00%
IBOGFUniversal Ibogaine Inc.	$0.02	+6.82%	-0.09	$7.35M	0.00%

About ProtoKinetix, Incorporated

ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.

ProtoKinetix, Incorporated (PKTX) stock trades at $0.00 with a market capitalization of $156632. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of 0.40, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, ProtoKinetix, Incorporated generates a return on equity (ROE) of -117.19%, return on capital employed of -104.22%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.protokinetix.com